Department of Clinical Pharmacology, Maulana Azad Medical College, Delhi, India.
Department of Cardiology, GB Pant Institute of Postgraduate Medical Education and Research, New Delhi, India.
Int J Cardiol. 2022 Sep 1;362:6-13. doi: 10.1016/j.ijcard.2022.05.023. Epub 2022 May 13.
Risk prediction following ST-Elevation Myocardial Infarction (STEMI) in resource limited countries is critical to identify patients at an increased risk of mortality who might benefit from intensive management.
North India ST-Elevation Myocardial Infarction (NORIN-STEMI) is an ongoing registry that has prospectively enrolled 3,635 STEMI patients. Of these, 3191 patients with first STEMI were included. Patients were divided into two groups: development (n=2668) and validation (unseen) dataset (n=523). Various ML strategies were used to train and tune the model based on validation dataset results that included 31 clinical characteristics. These models were compared in sensitivity, specificity, F1-score, receiver operating characteristic area under the curve (AUC), and overall accuracy to predict mortality at 30 days. ML model decision making was analyzed using the Shapley Additive exPlanations (ShAP) summary plot.
At 30 days, the mortality was 7.7%. On the validation dataset, Extra Tree ML model had the best predictive ability with sensitivity: 85%, AUC: 79.7%, and Accuracy: 75%. ShAP interpretable summary plot determined delay in time to revascularization, baseline cardiogenic shock, left ventricular ejection fraction <30%, age, serum creatinine, heart failure on presentation, female sex, and moderate-severe mitral regurgitation to be major predictors of all-cause mortality at 30 days (P<0.001 for all).
ML models lead to an improved mortality prediction following STEMI. ShAP summary plot for the interpretability of the AI model helps to understand the model's decision in identifying high-risk individuals who may benefit from intensified follow-up and close monitoring.
在资源有限的国家,对 ST 段抬高型心肌梗死(STEMI)后风险进行预测对于识别死亡率增加的患者至关重要,这些患者可能受益于强化管理。
印度北部 STEMI 登记研究(NORIN-STEMI)是一项正在进行的前瞻性登记研究,共纳入 3635 例 STEMI 患者。其中,3191 例首次 STEMI 患者被纳入研究。根据验证数据集(523 例未见过的患者)的结果,将患者分为两组:开发组(n=2668)和验证组。纳入 31 项临床特征,采用各种机器学习策略对模型进行训练和调优。这些模型在验证数据集上的敏感性、特异性、F1 评分、接受者操作特征曲线下面积(AUC)和总体准确性方面进行比较,以预测 30 天死亡率。使用 Shapley 可加性解释(ShAP)摘要图分析机器学习模型的决策。
30 天死亡率为 7.7%。在验证数据集上,Extra Tree ML 模型具有最佳的预测能力,敏感性为 85%,AUC 为 79.7%,准确性为 75%。可解释性 ShAP 摘要图确定了血管再通时间延迟、基线心源性休克、左心室射血分数<30%、年龄、血清肌酐、就诊时心力衰竭、女性和中重度二尖瓣反流是 30 天全因死亡率的主要预测因素(P<0.001)。
机器学习模型可提高 STEMI 后死亡率的预测能力。ShAP 摘要图有助于理解 AI 模型的决策,以识别可能受益于强化随访和密切监测的高危人群。